“Risperidone Versus Quetiapine: Risk of Developing Metabolic Syndromes in Patients Suffering from Psychiatry Disorders of a Health Care Center”. Asian Journal of Pharmaceutical and Health Sciences, vol. 10, no. 3, Sept. 2020, pp. 2309-17, https://doi.org/10.5530/1a3vgq24.